Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
TFF Pharmaceuticals, Inc. has filed 317 SEC EDGAR filings since 27 Mar 2018

SEC filing history

Showing 201-225 of 317 matching filings.

Per page
25
Current page
9
8-K File 001-39102

CURRENT REPORT

Filing date
10 Mar 2021
Reporting date
10 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Feb 2021
Reporting date
16 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Feb 2021
Reporting date
16 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91311

SC 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91311

SC 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Feb 2021
Reporting date
10 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91311

SC 13G/A

Filing date
03 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Jan 2021
Reporting date
19 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Jan 2021
Reporting date
25 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Jan 2021
Reporting date
15 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Dec 2020
Reporting date
23 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Dec 2020
Reporting date
23 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Dec 2020
Reporting date
11 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Dec 2020
Reporting date
07 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Dec 2020
Reporting date
04 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-249870

PROSPECTUS SUPPLEMENT

Filing date
08 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-249870

PROSPECTUS SUPPLEMENT

Filing date
04 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39102

FORM 8-K

Filing date
04 Dec 2020
Reporting date
04 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
04 Dec 2020
Reporting date
04 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Nov 2020
Reporting date
24 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-249870

EFFECT filing

Filing date
23 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
19 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-249870

AMENDMENT NO. 1 TO FORM S-3

Filing date
19 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Nov 2020
Reporting date
11 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Nov 2020
Reporting date
11 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .